Tonix Pharmaceuticals Holding Corp.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TNXP Company Description
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
TNXP Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TNXP Smart Score
Score Breakdown
TNXP Company Description
Show More
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TNXP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TNXP's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on TNXP's company Twitter account
WallStreetBets
Number of mentions of TNXP in WallStreetBets Daily Discussion
TNXP News
Recent insights relating to TNXP
CNBC Recommendations
Recent picks made for TNXP stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TNXP
Corporate Flights
Flights by private jets registered to TNXP
Our Analysis